Health Condition 1: R730- Abnormal glucose
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants with FBS between 100-125 mg/dl and/or OGTT between 140-199 mg/dl and/or HbA1c between 5.7%-6.4% Participants with presence of one or more unavoidable accessory circumstances like chronic stress, poor sleep hygeine, emotional conflicts, occupational stress, family related strain etc. Participants with no serious complications based on clinical evaluation Participants who give their valid consent to participate in the study
Exclusion criteria
Exclusion criteria: Participants who have diagnosed Type2 Diabetes Mellitus or any other systemic illness Participants who are on other medications for some other medical conditions or on antidiabetic medication of some other system Pregnant or lactating women Participants with a known psychiatric illness Participation in any other clinical trial during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate changes in glycemic levels (FBS, OGTT, HbA1c) before and after homoeopathic intervention and document and analyse the types of unavoidable accessory circumstances considered during remedy individualisationTimepoint: The study duration will be 16 months enrolment- 6 months follow up- 6 months data analysis- 2 months report writing- 2 months For statistical analysis FBS and OGTT will be recorded at baseline, 4 weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, and 24 weeks and HbA1c- at baseline, 12weeks and 24 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate changes in the symptom burden using Diabetes Symptom Checklist- RevisedTimepoint: baseline, 4 weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, 24 weeks | — |
Countries
India
Contacts
Bakson Homoeopathic Medical college and Hospital